check_circleStudy Completed

Magnetic Resonance Imaging

Bayer Identifier:

Trial_86149

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Gd-DTPA (SH L 451 AA) in magnetic resonance imaging of CNS lesions in teenage patients (13-18 years) (phase III)

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

12 - 18 Years
  • -

  • -

Trial summary

Enrollment Goal
26
Trial Dates
September 1986 - December 1987
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Magnevist (Gadopentetate Dimeglumine, BAY86-4882)
Accepts Healthy Volunteer
N/A

Trial design

Open, uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging of CNS lesions in teenage patients (13-18 years) (phase III)
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.